Navigator

      Support By : Li-lab

Drugs And Genes
Negative Drug Target Genes
GENE_SYMBOL DRUG_NAME Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) Potency (nM) AC50 (nM) Datasource
TOP2A Aesculioside IIk NA 250000 NA NA NA NA TTD
TOP2A Aesculioside IIIa NA 250000 NA NA NA NA TTD
TOP2A Aesculioside IIa NA 250000 NA NA NA NA TTD
TOP2A Eryngioside 94A NA 250000 NA NA NA NA TTD
TOP2A Aesculioside IIc NA 250000 NA NA NA NA TTD
TOP2A Aesculioside IId NA 250000 NA NA NA NA TTD
TOP2A 21-Angeloyl-protoaescigenin NA 250000 NA NA NA NA TTD
TOP2A Eryngioside F NA 250000 NA NA NA NA TTD
TOP2A Eryngioside E NA 250000 NA NA NA NA TTD
TOP2A Aesculioside IIId NA 250000 NA NA NA NA TTD
TOP2A Aesculioside IIIe NA 250000 NA NA NA NA TTD
TOP2A Aesculioside IIj NA 250000 NA NA NA NA TTD
TOP2A Aesculioside IIf NA 250000 NA NA NA NA TTD
TOP2A Aesculioside IIIc NA 250000 NA NA NA NA TTD
TOP2A Quinovic acid 28-O-beta-D-glucopyranosyl ester NA 250000 NA NA NA NA TTD
TOP2A 3-O-beta-6-deoxy-D-glucopyranosyl cincholic acid28-O-beta-D-glucopyranosyl ester NA 250000 NA NA NA NA TTD
TOP2A 3-O-alpha-L-rhamnopyranosyl quinovic acid NA 250000 NA NA NA NA TTD
TOP2A (1S,2R,4aS,6aR,6aR,6bR,8aR,10S,12aR,14bS)-10-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-1,2,6b,9,9,12a-hexamethyl-4a-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-6a-carboxylic acid NA 250000 NA NA NA NA TTD
TOP2A (1S,2R,4aS,6aR,6aR,6bR,8aR,10S,12aR,14bS)-4a-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxycarbonyl-1,2,6b,9,9,12a-hexamethyl-10-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-6a-carboxylic acid NA 250000 NA NA NA NA TTD
TOP2A N-((4-(2-chlorophenyl)-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-3-methoxybenzamide NA 1000000 NA NA NA NA TTD